title occurs: e.g.. boldlace USP or NF if current.

or specilic edition in lightface type ifnot

HO}T TO USE THIS BOOK

current
(5) Molecular formula and w'eight
(6) Chemical name(s)
(1) CAS registry' number(s)

For the most ef i'ect jr e u-se oi thts brruk. ilc re-rdc-r is

urged to reed rhe Prt''l'ttt'tnd ir'r cr.n.ulr thc ,is: ,.i -.1bret-atir.,n: s needed. In.rirJitr..n. thc- ioi.r'*.--{ lril:
and e\tnlflc>
book.

rie

pirr', rded

pr)iniL-:> Lrn

(8) Pharmacologic and,i s therapeutic activity claim

(italicized). based largely on representations
from the sponsor of the USAN and subject to

h\\ ti'L\e ihe

possible change as additional information becomes available

L S. \d-.::ei \.r::e is .:t,.r I :n boldface r., ne.

-, -:.ThcL>\\ --:-., ..:r I I L.S \d:,ei \.::'r.
il I \ er 'l pu: .;-,:.,,:' ;' : L S \\. -:. ::.,:.e:. .tnd
1l;. CiliC
,.:, P: i.-r-.:.. :. -- -Ech

(e) Brand name(s)

ol manufacturer(s) or distributor(s)
[a t s-v-mbol appears if the firm is no longer
concerned w'ith the productl
(11) Code designation(s), insofar as these have been

S\\

'

1'"'t'11':'

n',0]"n1""fl'/,ili1^',ii"J

_.__,!r2

-- -. :-,r-. :-r::. \
: : ._

.J--:: .. - --

used.

OTHER ILLT STR {TI\ E E\TRIES

Allopurinol [1964] (al oh pure' i nole).

USP.

CsHNO. 136.11. (l) 4H-Pyrazolo[3,,t-d]pyrimi{n-,tone, 1,5-dihydro- ; (2) 1,s-Dih ydr o- 4 H -pyr azolo [3,+d]t'yrimidin-4-one; (3) lH-Pyrazolo[3,4-d]pyrimidio-+ol-l CAS-

lNN.

Xanthine oxdase inhibitor. lyloprim

(Burroughs Wellcome)

+BW

@ "o'unciation guide
,^.
\! ) Cnemicatnames
iT,,'i{.ilfr'i,', frt,pharmacotosic and/or

therapeUtiC Categofy
-:. .-r-i _ - -.,..,-- j.r-.i:hrlphenethylamine hydrochloride.
- - -- i.- --.-v lchl.rphcnrcrrnin1. tnre.ric. ,-\
i,.,..,. ,. -. .i , .+ *s-'o:,. ri ux; i'ill ziis' '' (fi)
\-/ cod" designations

Manuf acture. ('l0\

or dislributot' \-'l

315-30-0.

3:r-r: ::, : -:r :. l-.hilrro-rr.rr-dimcthyl-. hydrochl.rridei \y

7;1
C,4S regisI..r 40 i l, 7
\-/

\,

(a2

.'

we'sh: (,

Brandname '0

12) Graphic formula

'e- :u:ttshedas usAN

s. Aio::e.: ra-e

and

E\TR\

fi\
\_./
Malec",ia, formula .,

rJ.

10) Name(s)

ascertained, preceded by the symbol

(-il Dr':t!i:,..i1.r4.1,. ,- -.-- -,1-.:'J:.1--: .:t *i:tCh

ILLL STR\TI\ E

56-158: NSC-l3W

,r'r\
"fl

. ncr

(O
\/

and/or firnr no longer conLFootnote l

TYPES OF ENTRIES IN THE BOOK

USAN (in boldface type)
Current USP and N F names (in boldface type)
Brand names
Code designations
CAS registry numbers and NSC numbers (Appendix

II)

Cross-references
Categories of pharmacologic and/or therapeutic activity
(See list by categories at end of main list)

orricHo-pmium
in which title occws

APPENDTXES

I-Guiding
I no1 propr ietary

nane

Acecarbromal. CeH 15BrN2O3. 279. 1 3.\1 -Acetyl-3-(a-brome

c-ethylbutyryl)urea. CAS-77-66-7. INN;

(Rikert)

MI.

Sedamyl

cH3coNHcoNHcoc(czH5)2

i,\

Principles

for Coining U. S. Adopted

Names for Drugs

ldentification as
i nternat i ona

Graphic formula

II-CAS

Registry Numbers and NSC Numbers

III-Molecular

IV

Formulas

Names and Addresses of Domestic Firms Concerned with Compounds for Which USAN Have
Been Selected

t\
{

Literature reference